Match-Making Reactors to Chemistry: A Continuous Manufacturing-Enabled Sequence to a Key Benzoxazole Pharmaceutical Intermediate
The focus of this study was to develop a chemical reaction sequence toward a key benzoxazole building block, required for clinical manufacturing of a lead candidate in the respiratory disease area.
Unit Operation: Reaction
Objective: General
Company: Novartis
Source: Org. Process Res. Dev., Article ASAP
Authors: Michel Aubry (Novartis), Julien Haber (Novartis), Fabio Lima (Novartis), Benjamin Martin (Novartis), Lorenzo Piccioni (Novartis), Berthold Schenkel (Novartis), Joerg Sedelmeie (Novartis), Serbuelent Sevinc (Novartis), Flavien Susanne (Novartis), Francesco Venturoni (Novartis)
Publish Date: 09-Oct-2017
Copyright © 2018 Scale-up Systems Ltd. | DynoChem Software and Development Services for the Pharma Industry | Privacy | Cookies | Contact